“I’m struggling to walk,” I’d plead. “To stand. At times, I can barely sit upright, let alone exercise.” But my words were ...

The menopausal transition may represent an inflection point for worsening of multiple sclerosis (MS) in women, accordi ...

New research helps explain why a subset of patients with relapsing/remitting multiple sclerosis (MS) experience long-term heart rate slowing after taking fingolimod. Various therapies have ...

Migraine may be a symptom of prodromal multiple sclerosis (MS), as the risk for migraine gradually increased closer to the ...

Relapsing-remitting multiple sclerosis is an unpredictable disease marked by relapses and remissions, but there are options ...

Gomez, whose first medication for treating her multiple sclerosis took the form of a daily, self-administered steroid ...

People with multiple sclerosis (MS) face a significantly higher risk of perinatal mental illness compared to those with other chronic conditions, according to a new study analyzing over 890,000 births ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.

A new study revealed safe MS treatment options during pregnancy, reassuring women to balance effective care with their plans ...